Jump to content

Lyrica, Pfizer, and how big pharma gets what it wants- From The Sydney Morning Herald


Andie

Recommended Posts

An investigation by The Sunday Age and The Sun-Herald has uncovered a sophisticated and well-funded effort by Pfizer to win government subsidy for the drug then promote it to doctors and consumers.  

 

In 2011, few had heard of Pfizer’s nerve-pain pill Lyrica. It was mostly confined to specialist pain clinics, doses kept low to minimise nasty side-effects.

Eight years later, it is one of Australia’s most prescribed drugs. More than 4 million scripts for pregabalin, the drug’s generic name, were written in 2017-18, costing government and consumers more than $171 million.

 

That’s come with a huge toll. An investigation by The Age revealed Pfizer’s ‘safe, non-addictive’ nerve-pain pill was highly addictive, dangerous when taken with other drugs, and came with a range of nasty side-effects - including suicidal thoughts.

 

The drug has been linked to more than 250 drug overdose deaths and six suicides. More than 85,000 Australians are abusing pregabalin, according to one study. Concerned doctors are scrambling to deal with the fallout.

 

https://www.smh.com.au/national/lyrica-pfizer-and-how-big-pharma-gets-what-it-wants-20190211-p50x1z.html

 

 

 

Current Dose

0.5mcg Clonidine and 1.25 Diazepam PRN for treatment of iatrogenic hypertension. 

2010 .Prescribed Pristiq 100 mg in July by GP

2010 .Reduced to 50mg by splitting and weighing. Held at 50mg

2014. Reduced from 50-35 .Held at 35mg. 

2017. Taper from 35mg commenced using compounded Desvenlafaxine

2018. 23/06 13.5mg. 21/07  12.5mg. 25/08 11.5mg. 09/2018 10mg. 14/11 11mg (updose) 21/11 -12mg (updose)

2019. Still holding at 12mg and stuck. 

2020. January 2019 Prozac Bridge-- Prozac 2.5 to 10mg and

Pristiq 23rd Jan 6mg/ 27th Jan 5mg/ 28th Jan 3mg/ 30 Jan 0

Prozac 6th Feb 9.5mg. Vitamin D3 5000iu with K2

Magnesium Glycinate with Glycine and Passionflower  600mg 

Link to comment
Share on other sites

×
×
  • Create New...

Important Information

Terms of Use Privacy Policy